“Mild Clinical Course of COVID-19 Infection in Chronic Myeloid Leukemia (CML) Patients Receiving Tyrosine Kinase Inhibitors (TKIs) Without Interruption”. Mediterranean Journal of Hematology and Infectious Diseases, vol. 13, no. 1, Feb. 2021, p. e2021022, https://doi.org/10.4084/mjhid.2021.022.